
The global market for On-Body Delivery System (OBDS) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The on-body delivery system (OBDS) market is changing rapidly, and it has become clear that OBDS are critical to the delivery of some new drugs in development. The OBDS market is relatively young, which lends itself to exciting innovations and high potential growth rate. Many companies have products that are still in development and have not yet been commercialized.
Report Scope
This report aims to provide a comprehensive presentation of the global market for On-Body Delivery System (OBDS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-Body Delivery System (OBDS).
The On-Body Delivery System (OBDS) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global On-Body Delivery System (OBDS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-Body Delivery System (OBDS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
West Pharmaceutical Services
Gerresheimer
Stevanato Group
Enable Injections
Insulet
Ypsomed
Bexson
Nemera
BD Medical
Segment by Type
Push Drug Out Of Container
Pull Drug Out Of Container
Segment by Application
Diabetes
Parkinson'S Disease
Cancer
Cardiovascular Diseases
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of On-Body Delivery System (OBDS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of On-Body Delivery System (OBDS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 On-Body Delivery System (OBDS) Market Overview
1.1 Product Definition
1.2 On-Body Delivery System (OBDS) by Type
1.2.1 Global On-Body Delivery System (OBDS) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Push Drug Out Of Container
1.2.3 Pull Drug Out Of Container
1.3 On-Body Delivery System (OBDS) by Application
1.3.1 Global On-Body Delivery System (OBDS) Market Value by Application (2024 VS 2031)
1.3.2 Diabetes
1.3.3 Parkinson'S Disease
1.3.4 Cancer
1.3.5 Cardiovascular Diseases
1.3.6 Other
1.4 Global On-Body Delivery System (OBDS) Market Size Estimates and Forecasts
1.4.1 Global On-Body Delivery System (OBDS) Revenue 2020-2031
1.4.2 Global On-Body Delivery System (OBDS) Sales 2020-2031
1.4.3 Global On-Body Delivery System (OBDS) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 On-Body Delivery System (OBDS) Market Competition by Manufacturers
2.1 Global On-Body Delivery System (OBDS) Sales Market Share by Manufacturers (2020-2025)
2.2 Global On-Body Delivery System (OBDS) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global On-Body Delivery System (OBDS) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of On-Body Delivery System (OBDS), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of On-Body Delivery System (OBDS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-Body Delivery System (OBDS), Product Type & Application
2.7 Global Key Manufacturers of On-Body Delivery System (OBDS), Date of Enter into This Industry
2.8 Global On-Body Delivery System (OBDS) Market Competitive Situation and Trends
2.8.1 Global On-Body Delivery System (OBDS) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest On-Body Delivery System (OBDS) Players Market Share by Revenue
2.8.3 Global On-Body Delivery System (OBDS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global On-Body Delivery System (OBDS) Market Scenario by Region
3.1 Global On-Body Delivery System (OBDS) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global On-Body Delivery System (OBDS) Sales by Region: 2020-2031
3.2.1 Global On-Body Delivery System (OBDS) Sales by Region: 2020-2025
3.2.2 Global On-Body Delivery System (OBDS) Sales by Region: 2026-2031
3.3 Global On-Body Delivery System (OBDS) Revenue by Region: 2020-2031
3.3.1 Global On-Body Delivery System (OBDS) Revenue by Region: 2020-2025
3.3.2 Global On-Body Delivery System (OBDS) Revenue by Region: 2026-2031
3.4 North America On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.4.1 North America On-Body Delivery System (OBDS) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America On-Body Delivery System (OBDS) Sales by Country (2020-2031)
3.4.3 North America On-Body Delivery System (OBDS) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.5.1 Europe On-Body Delivery System (OBDS) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe On-Body Delivery System (OBDS) Sales by Country (2020-2031)
3.5.3 Europe On-Body Delivery System (OBDS) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-Body Delivery System (OBDS) Market Facts & Figures by Region
3.6.1 Asia Pacific On-Body Delivery System (OBDS) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific On-Body Delivery System (OBDS) Sales by Region (2020-2031)
3.6.3 Asia Pacific On-Body Delivery System (OBDS) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.7.1 Latin America On-Body Delivery System (OBDS) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America On-Body Delivery System (OBDS) Sales by Country (2020-2031)
3.7.3 Latin America On-Body Delivery System (OBDS) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-Body Delivery System (OBDS) Market Facts & Figures by Country
3.8.1 Middle East and Africa On-Body Delivery System (OBDS) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa On-Body Delivery System (OBDS) Sales by Country (2020-2031)
3.8.3 Middle East and Africa On-Body Delivery System (OBDS) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-Body Delivery System (OBDS) Sales by Type (2020-2031)
4.1.1 Global On-Body Delivery System (OBDS) Sales by Type (2020-2025)
4.1.2 Global On-Body Delivery System (OBDS) Sales by Type (2026-2031)
4.1.3 Global On-Body Delivery System (OBDS) Sales Market Share by Type (2020-2031)
4.2 Global On-Body Delivery System (OBDS) Revenue by Type (2020-2031)
4.2.1 Global On-Body Delivery System (OBDS) Revenue by Type (2020-2025)
4.2.2 Global On-Body Delivery System (OBDS) Revenue by Type (2026-2031)
4.2.3 Global On-Body Delivery System (OBDS) Revenue Market Share by Type (2020-2031)
4.3 Global On-Body Delivery System (OBDS) Price by Type (2020-2031)
5 Segment by Application
5.1 Global On-Body Delivery System (OBDS) Sales by Application (2020-2031)
5.1.1 Global On-Body Delivery System (OBDS) Sales by Application (2020-2025)
5.1.2 Global On-Body Delivery System (OBDS) Sales by Application (2026-2031)
5.1.3 Global On-Body Delivery System (OBDS) Sales Market Share by Application (2020-2031)
5.2 Global On-Body Delivery System (OBDS) Revenue by Application (2020-2031)
5.2.1 Global On-Body Delivery System (OBDS) Revenue by Application (2020-2025)
5.2.2 Global On-Body Delivery System (OBDS) Revenue by Application (2026-2031)
5.2.3 Global On-Body Delivery System (OBDS) Revenue Market Share by Application (2020-2031)
5.3 Global On-Body Delivery System (OBDS) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Company Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 West Pharmaceutical Services On-Body Delivery System (OBDS) Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Gerresheimer
6.2.1 Gerresheimer Company Information
6.2.2 Gerresheimer Description and Business Overview
6.2.3 Gerresheimer On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gerresheimer On-Body Delivery System (OBDS) Product Portfolio
6.2.5 Gerresheimer Recent Developments/Updates
6.3 Stevanato Group
6.3.1 Stevanato Group Company Information
6.3.2 Stevanato Group Description and Business Overview
6.3.3 Stevanato Group On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Stevanato Group On-Body Delivery System (OBDS) Product Portfolio
6.3.5 Stevanato Group Recent Developments/Updates
6.4 Enable Injections
6.4.1 Enable Injections Company Information
6.4.2 Enable Injections Description and Business Overview
6.4.3 Enable Injections On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Enable Injections On-Body Delivery System (OBDS) Product Portfolio
6.4.5 Enable Injections Recent Developments/Updates
6.5 Insulet
6.5.1 Insulet Company Information
6.5.2 Insulet Description and Business Overview
6.5.3 Insulet On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Insulet On-Body Delivery System (OBDS) Product Portfolio
6.5.5 Insulet Recent Developments/Updates
6.6 Ypsomed
6.6.1 Ypsomed Company Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ypsomed On-Body Delivery System (OBDS) Product Portfolio
6.6.5 Ypsomed Recent Developments/Updates
6.7 Bexson
6.7.1 Bexson Company Information
6.7.2 Bexson Description and Business Overview
6.7.3 Bexson On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bexson On-Body Delivery System (OBDS) Product Portfolio
6.7.5 Bexson Recent Developments/Updates
6.8 Nemera
6.8.1 Nemera Company Information
6.8.2 Nemera Description and Business Overview
6.8.3 Nemera On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nemera On-Body Delivery System (OBDS) Product Portfolio
6.8.5 Nemera Recent Developments/Updates
6.9 BD Medical
6.9.1 BD Medical Company Information
6.9.2 BD Medical Description and Business Overview
6.9.3 BD Medical On-Body Delivery System (OBDS) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BD Medical On-Body Delivery System (OBDS) Product Portfolio
6.9.5 BD Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-Body Delivery System (OBDS) Industry Chain Analysis
7.2 On-Body Delivery System (OBDS) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-Body Delivery System (OBDS) Production Mode & Process Analysis
7.4 On-Body Delivery System (OBDS) Sales and Marketing
7.4.1 On-Body Delivery System (OBDS) Sales Channels
7.4.2 On-Body Delivery System (OBDS) Distributors
7.5 On-Body Delivery System (OBDS) Customer Analysis
8 On-Body Delivery System (OBDS) Market Dynamics
8.1 On-Body Delivery System (OBDS) Industry Trends
8.2 On-Body Delivery System (OBDS) Market Drivers
8.3 On-Body Delivery System (OBDS) Market Challenges
8.4 On-Body Delivery System (OBDS) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
West Pharmaceutical Services
Gerresheimer
Stevanato Group
Enable Injections
Insulet
Ypsomed
Bexson
Nemera
BD Medical
Ìý
Ìý
*If Applicable.
